ALXO - ALX Oncology P/S multiplikatori

alxoncology.com (ALXO) tovar belgisi

ALX Oncology Holdings (ALXO) kombinatsiyalangan terapiyadagi xavfsiz inhibitorlar orqali bozor ulushi uchun raqobatlashmoqda. Ishlab chiqish jarayoni klinik sinovlarning muvaffaqiyati va tashqi moliyalashtirishga tayanadi. Brendning yuqori nufuzi o'smalarga qarshi kurashish uchun efvapceptni ishlab chiqish bilan tasdiqlangan. Bozor kapitallashuvi va daromad nisbatining dinamikasi aktiv qiymatini baholashga yordam beradi, hozirda ushbu ko'rsatkich ga teng.

ALXO (ALX Oncology Holdings) Narxning daromadga nisbati tarixi 04.07.2022dan 18.11.2026gacha

ALX Oncology Holdings (ALXO) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning umumiy tahlili:ALX Oncology Holdings, ALXO
ALX Oncology Holdings Inc. ishlab chiqargan mahsulot

Ushbu ko'rsatkich bozor kapitalizatsiyasining yillik daromadga nisbati sifatida hisoblanadi va sotuvlarning har bir birligi xarajatini aks ettiradi. Ushbu koeffitsient biznesning haqiqiy pul oqimlari bilan solishtirganda bozor kutganlarini baholash imkonini beradi. ALX Oncology Holdings (ALXO) uchun, II/III bosqich klinik sinovlar kengayishi davrida, ushbu ko'rsatkich investorlarning kompaniya dori vositalarining kelgusidagi tijorat muvaffaqiyatiga bo'lgan ishonchi indikatori bo'lib xizmat qiladi. GURU.Markets platformasida narxning sotuvlarga nisbati koeffitsientini tahlil qilish kompaniyaning fundamental istiqbollaridan baholashdagi chetga chiqishlarni aniqlashga yordam beradi.

Raqobatdosh kompaniyalar

Kapitalizatsiyaning daromadga nisbati ImmunityBio Corp IBRX|Immunocore Holdings - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Janux Corp JANX|RCUS - Narxning daromadga nisbati|ZYME (zymeworks.com) - Kapitalizatsiya va daromad nisbati|Tango Therapeutics Corp (TNGX) - Narxning daromadga nisbati|Sotuvga nisbatan narx Iovance (IOVA)|Kapitalizatsiyaning daromadga nisbati IMTX|XNCR - Narx/daromad multiplikatori|Kapitalizatsiyaning daromadga nisbati CMPX (Compass Bio)|Kapitalizatsiyaning sotish hajmiga nisbati REPL|P/S multiplikatori LYEL (Lyell Immunopharma, Inc.)|Bozor kapitallashuvining daromadga nisbati IPHA|Pyxis - P/S multiplikatori|Sotuvga nisbatan narx Compugen|IO Biotech, Inc. (IOBT) - Narxning daromadga nisbati|Sutro Biopharma, Inc. - Bozor kapitallashuvining daromadga nisbati|INKT (minktherapeutics.com) - P/S multiplikatori|P/S multiplikatori werewolftx.com|Narxning daromadga nisbati immixbio.com (IMMX)|CUE - Sotuvga nisbatan narx|PDS Biotechnology Corporation - Kapitalizatsiyaning daromadga nisbati|Sonnet BioTherapeutics (SONN) - Sotuvga nisbatan narx|MAIA - Narxning daromadga nisbati|LIMN: Narxning daromadga nisbati|LVTX: P/S multiplikatori|Sotuvga nisbatan narx NextCure, Inc. (NXTC)|LPTX (Leap Tx) - P/S multiplikatori|INTS (Intensity Therapeutics) - Kapitalizatsiyaning sotish hajmiga nisbati|Narxning daromadga nisbati Sensei Bio (SNSE)|TOVX (Theriva Biologics) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati gritstonebio.com GRTS|Bozor kapitallashuvining daromadga nisbati KA|NEXI - Narxning daromadga nisbati|Turnstone Biologics Corp. - Kapitalizatsiyaning sotish hajmiga nisbati|VCNX: P/S multiplikatori|Kapitalizatsiya va daromad nisbati HARP